BioSpace News Archive

Precigen, Inc. today released highlights of pipeline updates to be presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 at 5:15 PM PST in San Francisco, California.

Aditxt, Inc. today announces that the Company and its subsidiary, Pearsanta, Inc. (“Pearsanta”), has acquired MDNA Life Sciences Inc.’s (“MDNA”) proprietary, early disease and cancer detection platform.

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, provided a business update on portfolio programs.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it will commence immediately with an orderly wind down of the Advanced Circulatory Support (ACS) Business Unit to increase the Company’s strategic focus on its core Cardiopulmonary (CP) and Neuromodulation Business Units.

Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices – Dream Sock ® and BabySat ™.

BioMatrix Specialty Pharmacy is pleased to announce the appointment of Ted Kramm to the Board of Directors.

Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2023 and provided product revenue guidance for full-year 2024.

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit.

PharmAla Biotech Holdings Inc. is proud to announce that it has received approval to move its PharmAla-1 (P1) molecule through the US Patent and Trademark Office (USPTO) Patent Prosecution Highway pathway based on the positive Patent Cooperation Treaty (PCT) initial office action previously announced by PharmAla.

GeneDx Holdings Corp. today reported preliminary financial results for the fourth quarter and full year of 2023.